GASTROINTESTINAL TOLERABILITY OF ONCE-WEEKLY SEMAGLUTIDE 2.4 MG IN ADULTS WITH OVERWEIGHT OR OBESITY, AND THE RELATIONSHIP BETWEEN GASTROINTESTINAL ADVERSE EVENTS AND WEIGHT LOSS